Aptose Biosciences Inc (APTOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 4,913 | 6,921 | 5,461 | 2,187 | 6,965 |
| Operating Income | -4,913 | -6,921 | -5,461 | -2,187 | -6,965 |
| Interest Expense | 212 | 110 | 84 | 433 | -12 |
| Other Income | 2 | -12 | 2 | 1,035 | 0 |
| Pre-tax Income | -5,123 | -7,043 | -5,543 | -1,585 | -6,953 |
| Net Income Continuous | -5,123 | -7,043 | -5,543 | -1,585 | -6,953 |
| Net Income | $-5,123 | $-7,043 | $-5,543 | $-1,585 | $-6,953 |
| EPS Basic Total Ops | -2.01 | -2.76 | -2.61 | 9.96 | -11.33 |
| EPS Basic Continuous Ops | -2.01 | -2.76 | -2.61 | 9.96 | -11.33 |
| EPS Diluted Total Ops | -2.01 | -2.76 | -2.61 | 9.96 | -11.33 |
| EPS Diluted Continuous Ops | -2.01 | -2.76 | -2.61 | 9.96 | -11.33 |
| EPS Diluted Before Non-Recurring Items | -2.01 | -2.76 | -2.61 | N/A | -11.11 |
| EBITDA(a) | $-4,802 | $-6,819 | $-5,362 | $-2,090 | $-6,869 |